Reuters logo
BRIEF-Axovant Sciences appoints David Hung as CEO
April 10, 2017 / 12:51 PM / 7 months ago

BRIEF-Axovant Sciences appoints David Hung as CEO

April 10 (Reuters) - Axovant Sciences Ltd

* Axovant Sciences announces appointment of Dr. David Hung as chief executive officer and expansion of board of directors

* Axovant Sciences Ltd - Mindset study results for intepirdine in mild-to-moderate Alzheimer’s disease expected in late September 2017

* Axovant Sciences Ltd says Mindset study results for intepirdine in mild-to-moderate Alzheimer’s disease expected in late September 2017

* Vivek Ramaswamy to remain on board of directors and assume full-time role as CEO of parent company Roivant sciences

* Axovant Sciences Ltd- also announced appointment of Marion Mccourt as president and chief operating officer

* Axovant Sciences Ltd - Hung, who also joined Axovant’s board of directors, succeeds founding chief executive officer Vivek Ramaswamy

* Former medivation directors Kate Falberg and Tony Vernon appointed to board of directors

* Axovant Sciences Ltd - David Hung has been named chief executive officer of Axovant Sciences, effective April 7, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below